Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001019687-15-002805
Filing Date
2015-07-20
Accepted
2015-07-20 13:42:09
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT xenetic_10ka3-123113.htm 10-K/A 32981
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER xenetic_10ka-ex3101.htm EX-31.1 8069
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER xenetic_10ka-ex3102.htm EX-31.2 8036
4 CERTIFICATION xenetic_10ka-ex3201.htm EX-32.1 3448
  Complete submission text file 0001019687-15-002805.txt   4578383

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20131231.xml EX-101.INS 842341
6 XBRL SCHEMA FILE xbio-20131231.xsd EX-101.SCH 65364
7 XBRL CALCULATION FILE xbio-20131231_cal.xml EX-101.CAL 88202
8 XBRL DEFINITION FILE xbio-20131231_def.xml EX-101.DEF 322172
9 XBRL LABEL FILE xbio-20131231_lab.xml EX-101.LAB 462110
10 XBRL PRESENTATION FILE xbio-20131231_pre.xml EX-101.PRE 411567
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-178082 | Film No.: 15995593
SIC: 2834 Pharmaceutical Preparations